752 related articles for article (PubMed ID: 26727723)
1. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
Toth A; Nagy H; Wacha J; Bereczki D; Takáts A
Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies with levodopa/carbidopa intestinal gel].
Klivényi P; Vécsei L
Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
[TBL] [Abstract][Full Text] [Related]
3. [Experience with levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary].
Nagy H; Takáts A; Tóth A; Bereczki D; Klivényi P; Dézsi L; Dibó G; Vécsei L; Kovács N; Aschermann Z; Komoly S; Varannai L; Zemlényi G; Valikovics A
Ideggyogy Sz; 2014 Nov; 67(11-12):385-9. PubMed ID: 25720240
[TBL] [Abstract][Full Text] [Related]
4. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
[TBL] [Abstract][Full Text] [Related]
5. [Treatment possibilities in advanced Parkinson's disease].
Takáts A; Nagy H; Radics P; Tóth A; Tamás G
Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235
[TBL] [Abstract][Full Text] [Related]
6. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
Antonini A; Fung VS; Boyd JT; Slevin JT; Hall C; Chatamra K; Eaton S; Benesh JA
Mov Disord; 2016 Apr; 31(4):530-7. PubMed ID: 26817533
[TBL] [Abstract][Full Text] [Related]
7. Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease.
Nyholm D; Klangemo K; Johansson A
Eur J Neurol; 2012 Aug; 19(8):1079-85. PubMed ID: 22360705
[TBL] [Abstract][Full Text] [Related]
8. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
Antonini A; Yegin A; Preda C; Bergmann L; Poewe W;
Parkinsonism Relat Disord; 2015 Mar; 21(3):231-5. PubMed ID: 25585993
[TBL] [Abstract][Full Text] [Related]
9. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel.
Marano M; Naranian T; di Biase L; Di Santo A; Poon YY; Arca R; Cossu G; Marano P; Di Lazzaro V; Fasano A
Parkinsonism Relat Disord; 2019 Dec; 69():140-146. PubMed ID: 31759188
[TBL] [Abstract][Full Text] [Related]
10. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
[TBL] [Abstract][Full Text] [Related]
11. Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease.
Timpka J; Fox T; Fox K; Honig H; Odin P; Martinez-Martin P; Antonini A; Chaudhuri KR
Acta Neurol Scand; 2016 Jun; 133(6):451-8. PubMed ID: 26358227
[TBL] [Abstract][Full Text] [Related]
12. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
13. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.
Buongiorno M; Antonelli F; Cámara A; Puente V; de Fabregues-Nebot O; Hernandez-Vara J; Calopa M; Pascual-Sedano B; Campolongo A; Valldeoriola F; Tolosa E; Kulisevsky J; Martí MJ
Parkinsonism Relat Disord; 2015 Aug; 21(8):871-6. PubMed ID: 26003410
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.
Nyholm D; Odin P; Johansson A; Chatamra K; Locke C; Dutta S; Othman AA
AAPS J; 2013 Apr; 15(2):316-23. PubMed ID: 23229334
[TBL] [Abstract][Full Text] [Related]
15. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW; Kieburtz K; Odin P; Espay AJ; Standaert DG; Fernandez HH; Vanagunas A; Othman AA; Widnell KL; Robieson WZ; Pritchett Y; Chatamra K; Benesh J; Lenz RA; Antonini A;
Lancet Neurol; 2014 Feb; 13(2):141-9. PubMed ID: 24361112
[TBL] [Abstract][Full Text] [Related]
16. Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.
Dam-Larsen S; Darkahi B; Glad A; Gleditsch D; Gustavsson L; Halttunen J; Johansson KE; Pischel A; Reiertsen O; Törnqvist B; Zebski H
Scand J Gastroenterol; 2015; 50(12):1500-7. PubMed ID: 26083798
[TBL] [Abstract][Full Text] [Related]
17. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
Nyholm D
Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
[TBL] [Abstract][Full Text] [Related]
18. Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
Poewe W; Bergmann L; Kukreja P; Robieson WZ; Antonini A
J Parkinsons Dis; 2019; 9(3):531-541. PubMed ID: 31282424
[TBL] [Abstract][Full Text] [Related]
19. Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
Lang AE; Rodriguez RL; Boyd JT; Chouinard S; Zadikoff C; Espay AJ; Slevin JT; Fernandez HH; Lew MF; Stein DA; Odin P; Fung VS; Klostermann F; Fasano A; Draganov PV; Schmulewitz N; Robieson WZ; Eaton S; Chatamra K; Benesh JA; Dubow J
Mov Disord; 2016 Apr; 31(4):538-46. PubMed ID: 26695437
[TBL] [Abstract][Full Text] [Related]
20. Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration.
Jost WH
Expert Opin Drug Saf; 2014 Apr; 13(4):447-58. PubMed ID: 24611456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
